KalVista Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:KALV) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 32.68 M40.36 M54.5 M32.12 M 159.67 M Cash from investing activities 8.52 M-3.33 M21.26 M1.94 M 28.39 M Cash from financing activities 151.77 M4.66 M23.21 M136.52 M 316.16 M Free cash flow 32.55 M39.85 M54.06 M30.81 M 157.28 M

新闻

KalVista Pharma首席财务官Piekos出售价值27,506美元股票

KalVista Pharma首席医疗官Audhya出售8.3万美元股票

KalVista Pharma首席商务官Sweeny出售6.19万美元股票

KalVista Pharma首席开发官出售6.77万美元股票

KalVista Pharma首席执行官Palleiko出售15.6万美元股票以履行纳税义务

国际指南推荐EKTERLY作为HAE一线治疗药物

International guideline recommends EKTERLY as first-line HAE therapy

KalVista: Next Stage Of Growth For EKTERLY Lies With Pediatric Label Expansion (KALV)

Wall Street Analysts Believe KalVista Pharmaceuticals (KALV) Could Rally 116.4%: Here's is How to Trade

美国银行推荐2026年值得关注的四大生物科技股

BofA’s Top Four Biotech Stocks to Watch in 2026

Does KalVista Pharmaceuticals (KALV) Have the Potential to Rally 117.98% as Wall Street Analysts Expect?